Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, July 1999, p. 494-498, Vol. 6, No. 4
Departments of Laboratory
Medicine,1
Pediatrics,3 and
Stomatology,2 Schools of Medicine and
Dentistry, University of California at San Francisco, San
Francisco, California 94143
Received 25 November 1998/Returned for modification 26 January
1999/Accepted 29 March 1999
Cytotoxic T-lymphocyte (CTL) responses to E6 and E7 were previously
shown to be more commonly detectable in human papillomavirus type 16 (HPV-16)-positive women without squamous intraepithelial neoplasia (SIL) than in HPV-16-positive women with SIL (M. Nakagawa, D. P. Stites, S. Farhat, J. R. Sisler, B. Moss, F. Kong,
A. B. Moscicki, and J. M. Palefsky, J. Infect. Dis.
175:927-931, 1997). The objective of this study was to characterize
the phenotype(s) of the effector cell population responsible for HPV-16
E6- and E7-specific cytotoxic responses. Peripheral blood mononuclear cells were stimulated with HPV-16 E6 or E7 fusion protein. Cells from
an autologous B-lymphoblastoid cell line, infected with vaccinia virus
expressing E6 or E7, served as target cells. The effector cells were
characterized by using natural-killer-cell removal, antibody blocking,
and T-cell subset separation. Our results suggest that both CD4 and CD8
T lymphocytes contribute to HPV-16 E6- and E7-specific CTL responses
although their relative contributions vary from individual to
individual. On the other hand, natural killer cells in the effector
cell population contribute to background activities but not to
HPV-specific responses in this assay system.
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
CD4-Positive and CD8-Positive Cytotoxic T Lymphocytes Contribute
to Human Papillomavirus Type 16 E6 and E7 Responses
*
Corresponding author. Mailing address: Box 0134, Department of Laboratory Medicine, School of Medicine, University of
California at San Francisco, San Francisco, CA 94143-0134. Phone: (415)
476-1394. Fax: (415) 476-6322. E-mail:
mayumi{at}pangloss.ucsf.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |